Pharma Journalist - Page 77 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Astellas Partners with Japanese Cancer Foundation to Boost Oncology Research

EU Approves Pfizer’s RSV Vaccine ABRYSVO for Adults 18-59

Apellis Gets FDA Priority Review for EMPAVELI in C3G, IC-MPGN

AIRNA Secures $155M in Oversubscribed Series B for Alpha-1 Antitrypsin Trial

Amneal Launches BORUZU, First Ready-to-Use Bortezomib Injection

Bavarian Nordic Gets FDA Approval for Smallpox, Mpox Vaccine

Qfitlia Approved as First US Therapy for Hemophilia A/B with or without Inhibitors

Imfinzi Approved as First Perioperative Immunotherapy for Bladder Cancer

Lexicon Pharmaceuticals Signs Exclusive License Agreement with Novo Nordisk for LX9851

Ionis Expands Partnership with Sobi for Olezarsen Commercialization Outside the U.S.